Novel Bioactive Paulomycin Derivatives Produced by Streptomyces albus J1074

1Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

Four novel paulomycin derivatives have been isolated from S. albus J1074 grown in MFE culture medium. These compounds are structural analogs of antibiotics 273a2α and 273a2β containing a thiazole moiety, probably originated through an intramolecular Michael addition. The novel, thiazole, moiety-containing paulomycins show a lower antibiotic activity than paulomycins A and B against Gram-positive bacteria. However, two of them show an improved activity against Gram-negative bacteria. In addition, the four novel compounds are more stable in culture than paulomycins A and B. Thus, the presence of an N-acetyl-l-cysteine moiety linked to the carbon atom of the paulic acid isothiocyanate moiety, via a thioester bond, and the subsequent intramolecular cyclization of the paulic acid to generate a thiazole heterocycle confer to paulomycins a higher structural stability that otherwise will conduce to paulomycin degradation and into inactive paulomenols.

Cite

CITATION STYLE

APA

Hoz, J. F. D. la, Méndez, C., Salas, J. A., & Olano, C. (2017). Novel Bioactive Paulomycin Derivatives Produced by Streptomyces albus J1074. Molecules (Basel, Switzerland), 22(10). https://doi.org/10.3390/molecules22101758

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free